PDS Biotechnology (PDSB) Tops Q3 EPS by 2c
Get Alerts PDSB Hot Sheet
Join SI Premium – FREE
PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c
- SunEdison (SUNE) Misses Q2 EPS by 52c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share